Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Study Evaluating the Effect of Losartan
Sponsor: Tanta University
Summary
The pancreas is two organs packaged into one. The islets of Langerhans serve critical endocrine functions, and the exocrine portion is a major source of enzymes that are essential for digestion. Pancreatic cancer (PC) is more commonly referred to as pancreatic infiltrating ductal adenocarcinoma in addition to being the second leading cause of cancer death in the United States, after lung cancer in 2020. Whereas pancreatic cancer is the seventh cause of death from cancer in Asia in 2020. Although it is substantially less common than the other malignancies, pancreatic carcinoma is near the top of the list of killers because it is a highly aggressive carry.
Official title: Clinical Study Evaluating the Effect of Losartan on Response Rate in Both Metastatic and Locally Advanced Pancreatic Cancer Patients
Key Details
Gender
All
Age Range
50 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
90
Start Date
2024-07-20
Completion Date
2026-08-20
Last Updated
2024-08-06
Healthy Volunteers
No
Conditions
Interventions
Losartan 50mg Tab
The efficacy of losartan on response rate in both metastatic and locally advanced pancreatic cancer patients
Locations (1)
Tanta University Hospital
Tanta, Egypt